AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie kaletra (lopinavir/ritonavir) [legacy through FY20Q1] — Worldwide net revenues ($M) ($M)
Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Key Product Revenues
Latest, Q1 2020
86
Period ended Mar 31, 2020
Change on a year earlier
+10.3%
78 in Q1 2019
History
13 quarters
Since Q1 2017
Sources
8
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Kaletra (lopinavir/ritonavir) [legacy through FY20Q1] — Worldwide net revenues ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 2020 | Mar 31, 2020 | 86 | +10.3% | Form 10-Q (filed 2020-05-08) ↗ |
| Q4 2019 | Dec 31, 2019 | 54 | -35.7% | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2019 | Sep 30, 2019 | 74 | -15.9% | Form 10-Q (filed 2019-11-06) ↗ |
| Q2 2019 | Jun 30, 2019 | 77 | -15.4% | Form 10-Q (filed 2019-08-05) ↗ |
| Q1 2019 | Mar 31, 2019 | 78 | +6.8% | Form 10-Q (filed 2020-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 84 | -25.7% | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2018 | Sep 30, 2018 | 88 | +3.5% | Form 10-Q (filed 2019-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 91 | -17.3% | Form 10-Q (filed 2019-08-05) ↗ |
| Q1 2018 | Mar 31, 2018 | 73 | -36.5% | Form 10-Q (filed 2019-05-03) ↗ |
| Q4 2017 | Dec 31, 2017 | 113 | – | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2017 | Sep 30, 2017 | 85 | – | Form 10-Q (filed 2018-11-07) ↗ |
| Q2 2017 | Jun 30, 2017 | 110 | – | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2017 | Mar 31, 2017 | 115 | – | Form 10-Q (filed 2018-05-04) ↗ |
Breakdown
What makes up kaletra (lopinavir/ritonavir) [legacy through fy20q1] — worldwide net revenues ($m)
Cite this data
StockData. (2026). AbbVie Kaletra (lopinavir/ritonavir) [legacy through FY20Q1] — Worldwide net revenues ($M) ($M), quarterly Q1 2017–Q1 2020 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/kaletra_ww
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.